A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
COX2: A Prognostic Inflammogenic Marker Drives Cervical Carcinogenesis in Vivo through the NFκB/IAP/p53Axis
[post]
2021
unpublished
Cycloxygenase 2, a prostaglandin synthesizing enzyme, is a key player in inflammation-induced vasculogenesis that enables tumor growth. This study explores the central role of COX2 and its relative prosurvival proteins in evoking inflammatory events during the development of an in vivo cervical cancer model upon chronic treatment with 3-methylcholanthrene (3MC; a chemical carcinogen) in virgin-female Swiss albino mice. Chronic painting of the mouse cervix with 3MC solution triggered the
doi:10.21203/rs.3.rs-849980/v1
fatcat:4s4oihd4dnhatcm6ie5tp2qzie